Maximilian Diehn, MD/PHD
Basic profileKaplan-Lebeson Professor of Cancer Biology, Radiation Oncology - Radiation Therapy · Stanford Medicine
Maximilian Diehn is Kaplan-Lebeson Professor of Cancer Biology, Radiation Oncology - Radiation Therapy at Stanford Medicine. OpenAlex indexes 754 publications with 56,219 citations (h-index 90); ClinicalTrials.gov lists 4 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 1% of Radiation Oncology profiles in the findmyKOL directory.
Overview
Updated 18 Oct 2026
Maximilian Diehn, M.D./PH.D., is Kaplan-Lebeson Professor of Cancer Biology, Radiation Oncology - Radiation Therapy at Stanford University School of Medicine. The public record shows 841 publications with 56,961 citations (h-index 90), centered on Lung Cancer Diagnosis and Treatment, Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 8 companies, 11 NIH-funded awards (2013–2026).
- Most recent indexed publication: 2026 · Nature medicine
- Top research focus: Lung Cancer Diagnosis and Treatment
- 6 registered trials on ClinicalTrials.gov
- Open Payments reporting from 8 companies
Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 205.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
875 Blake Wilbur Dr.
Dept. Of Radiation Oncology (mc-5847)
Stanford, CA 94305-5847
Telephone
650-723-6171Registry record last updated 17 Sept 2007 · collected 28 Jul 2026.
Clinical trials
Updated 18 Oct 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
Industry payments
Updated 18 Oct 2026
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Chugai Pharmaceutical Co., Ltd.Program year20251 payment
- AstraZeneca UK LimitedProgram year20251 payment
- AstraZeneca Pharmaceuticals LPProgram year20242 payments
NIH funding
Updated 18 Oct 2026
11 NIH research awards on record, funded 2013–2026 per NIH RePORTER. The latest:
- Molecular Strategies to Widen the Therapeutic Index of Radiotherapy
Stanford University
FY2026$1,961,045P01CA257907 - Integrating Genomic & Epigenomic Features for Noninvasive Characterization of T-Cell Lymphomas
Stanford University
FY2026$638,972R01CA315638 - Noninvasive imaging and blood biomarkers for personalized lung cancer immunotherapy
Stanford University
FY2026$627,242R01CA290715
Congress activity
Updated 18 Oct 2026
231 congress contributions (2005–2026) across AACR, ASCO, ASH, ASTRO, ESMO per OpenAlex. The most recent:
- Abstract 1957: DNA methylation differentiates early-stage lung adenocarcinoma cells-of-origin with distinct smoking history and grade.
AACR Annual Meeting
AACR2026Co-author - Abstract 5270: Cell-free RNA changes precede symptomatic radiation pneumonitis in cancer patients receiving thoracic radiotherapy
AACR Annual Meeting
AACR2026Co-author - Abstract B033: Integrating spatial biology and peripheral blood biomarkers to map treatment resistance in pancreatic ductal adenocarcinoma
AACR (meeting unresolved)
AACR2026Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 18 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Urine cell-free RNA for bladder cancer detection and treatment response prediction.
Nature medicine
Article2026 - A targetable FTO/SLC7A11/CBS/CTH axis controls cysteine metabolism, growth and survival in NSCLC.
Science advances
Article2026 - Remission Assessment by Circulating Tumor DNA in Large B-Cell Lymphoma.
Journal of clinical oncology
Article2025 - CAR19 therapy drives expansion of clonal hematopoiesis and associated cytopenias.
Research square
Article2025
Most-cited works
by citation count (OpenAlex)- 01Robust enumeration of cell subsets from tissue expression profilesArticle13,164 citations2015
- 02Determining cell type abundance and expression from bulk tissues with digital cytometryArticle4,490 citations2019
- 03The prognostic landscape of genes and infiltrating immune cells across human cancersArticle3,120 citations2015
- 04Association of reactive oxygen species levels and radioresistance in cancer stem cellsArticle2,551 citations2009
- 05An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverageArticle2,216 citations2014
Network
Updated 18 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 18 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →profiles.stanford.edu ↗
Editorial & leadership roles
journal and society appointments- Scientific Editor
Cancer Discovery
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aacr.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.stanford.edu ↗
- Committee Member
American Society of Clinical Oncology (ASCO)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aacr.org ↗ - Committee Member
American Association for Cancer Research (AACR)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aacr.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pmwcintl.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.stanford.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →foresight-dx.com ↗
- Co-leader
Cancer Biology Program, Stanford Cancer Institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.stanford.edu ↗ - Institute for Stem Cell Biology & Regenerative Medicine
Stanford University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.stanford.edu ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pmwcintl.com ↗
- Speaker
Stanford Urology Research Day, August 14, 2026 - Presentation: Urine Liquid Biopsies for Bladder Cancer Detection and Molecular Characterization
2026provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →urology.stanford.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pmwcintl.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Charles Debattista, MD
Stanford Medicine
Michael Amylon, MD
Stanford Medicine
Kimberly Dequattro, MD, MM
Stanford Medicine
Tami John, MD
Stanford Medicine
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”